首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists
Authors:Sato Ippei  Morihira Koichiro  Inami Hiroshi  Kubota Hirokazu  Morokata Tatsuaki  Suzuki Keiko  Hamada Noritaka  Iura Yosuke  Nitta Aiko  Imaoka Takayuki  Takahashi Toshiya  Takeuchi Makoto  Ohta Mitsuaki  Tsukamoto Shin-ichi
Institution:Drug Discovery Research, Astellas Pharma Inc., 21Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan. ippei.sato@jp.astellas.com
Abstract:A novel class of potent CCR3 receptor antagonists were designed and synthesized starting from N-{1-(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide (1),which was found by subjecting our chemical library to high throughput screening (HTS). The CCR3 inhibitory activity of the synthesized compounds against eotaxin-induced Ca(2+) influx was evaluated using CCR3-expressing preB cells. Systematic chemical modifications of 1 revealed that the 6-fluoro-2-naphthylmethyl moiety was essential for CCR3 inhibitory activity in this new series of CCR3 antagonists. Further structural modifications of the benzamide and piperidine moieties of 1 led to the identification of exo-N-{8-(6-fluoro-2-naphthyl)methyl]-8-azabicyclo3.2.1]oct-3- yl}biphenyl-2-carboxamide corrected] (31) as a potent CCR3 antagonist with an IC(50) value of 0.020 microM.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号